Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone

por Kähkönen, Tiina E., Suominen, Mari I., Mäki-Jouppila, Jenni H. E., Halleen, Jussi M., Tanaka, Azusa, Seiler, Michael, Bernoulli, Jenni
Publicado 2019

Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells’ sensitivity to paclitaxel

por Tambe, Mahesh, Pruikkonen, Sofia, Mäki-Jouppila, Jenni, Chen, Ping, Elgaaen, Bente Vilming, Straume, Anne Hege, Huhtinen, Kaisa, Cárpen, Olli, Lønning, Per Eystein, Davidson, Ben, Hautaniemi, Sampsa, Kallio, Marko J.
Publicado 2016

Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse Model

por Suominen, Mari I., Mäki-Jouppila, Jenni, Huhtinen, Anna, Sjöholm, Birgitta, Rissanen, Jukka P., Luostarinen, Anniina, Fagerlund, Katja M., Alhoniemi, Esa, Siemeister, Gerhard, Mumberg, Dominik, Käkönen, Sanna-Maria, Scholz, Arne
Publicado 2021

VTT-006, an anti-mitotic compound, binds to the Ndc80 complex and suppresses cancer cell growth in vitro

por Laine, Leena J., Mäki-Jouppila, Jenni H.E., Kutvonen, Emma, Tiikkainen, Pekka, Nyholm, Thomas K.M., Tien, Jerry F., Umbreit, Neil T., Härmä, Ville, Kallio, Lila, Davis, Trisha N., Asbury, Charles L., Poso, Antti, Gorbsky, Gary J., Kallio, Marko J.
Publicado 2021